Re-sensitization to pembrolizumab following PSMA-CD3 T-cell redirection therapy with JNJ-081 in a patient with mismatch repair-deficient metastatic castration-resistant prostate cancer: a case report
=======================================================================================================================================================================================================

* Darien E Reed-Perino
* Michael Lai
* Evan Y Yu
* Michael T Schweizer